Article online on Erlotinib resistance in an EGFR Activating Mutated NSCLC
News from Mar 30, 2021
The manuscript “Constitutive Cell Proliferation Regulating Inhibitor of Protein Phosphatase 2A (CIP2A) Mediates Drug Resistance to Erlotinib in an EGFR Activating Mutated NSCLC Cell Line” by Saafan, Alahdab, Michelet et al. has been accepted in the journal Cells and is available online now.